// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

35,228
Stories Indexed
Live
Feed Status
6
Data Sources
LATEST
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
LEADERSHIP · 35,228 results Live
Leadership OTC:LCTC Sep 29 — 0.00

Lifoc Technologies participates in Lytham Partners virtual investor conference

Lifeloc Technologies will present its breath alcohol and new drug testing product strategy at the Lytham Partners virtual conference on September 29-30, 2026.

Leadership PAA · PAGP Sep 29 — 0.00

Plains Appoints Senior VP Liollio as New COO, Effective Oct 2

Plains All American Pipeline announced Dean Liollio as the new Executive Vice President and Chief Operating Officer, replacing Chris Chandler, who resigned. The appointment follows…

Leadership NVC Sep 29 — 0.00

Board Extended CEO Employment Agreement Through June 2027

NanoViricides and Anil Diwan extended his executive employment agreement for an additional year through June 30, 2027, and increased base salary to $400,000. This leadership event …

Leadership PAA · PAGP Sep 29 — 0.00

Plains Appoints Dean Liollio as Executive Vice President and Chief Operating Officer

Plains All American Pipeline and Plains GP Holdings announced the appointment of Dean Liollio as Executive Vice President and Chief Operating Officer, effective October 2, 2026, su…

Leadership APYX Sep 29 ▲ +0.50

Renuvion clinical study confirms skin quality improvements

Results published in Plastic and Reconstructive Surgery show Renuvion significantly increased elastin density and reduced inflammation. CEO Goodwin stated this validates the techno…

Leadership LARO Sep 29 — 0.00

La Rosa Holdings secures Board of Directors agreement with Marc Urbach dated Sept. 24, 2026

La Rosa Holdings Corp. entered into a Board of Directors agreement with Marc Urbach, effective September 24, 2026. The agreement appoints Urbach to the board as an independent cont…

Leadership AYI Sep 29 ▲ +0.50

Acuity Inc. Appoints Nick Tzitzon to Board

Acuity Inc. appointed Nick Tzitzon to its board to bolster leadership and strategy. His AI expertise aligns with the firm's vision for digital growth.

Leadership LWLG Sep 29 — +0.10

Lightwave Logic Appoints Kennedy to Board

Lightwave Logic has appointed Edward H. Kennedy to its board of directors. His telecom and networking experience may support the company's strategy for photonic devices used in AI …

Leadership BAYF Sep 29 — 0.00

BayFirst Amends COO Employment Agreement

BayFirst Financial Corp. amends its amended and restated employment agreement for COO Robin L. Oliver. This change requires a submission of Form 8-K.

Leadership FHLBI Sep 29 — 0.00

FHLBank Indianapolis announces leadership changes

The Federal Home Loan Bank of Indianapolis announced several executive promotions and organizational changes. These updates aim to enhance coordination and focus on the Bank's stra…

Leadership TMC Sep 29 — +0.10

TMC appoints ExxonMobil former upstream President to board

TMC announces the appointment of Liam Mallon, former President of ExxonMobil Upstream, to its Board to advance deep seabed mineral operations. The addition of a veteran energy exec…

Leadership HOST Sep 29 — 0.00

Host Digital CEO publishes letter to shareholders

Host Digital's CEO announces the completion of a merger and details the company's strategy for developing RightScaled data centers for AI and HPC.

Leadership NAMS Sep 29 — 0.00

NAMS Doses First SPINOZA Participant

NewAmsterdam Pharma began a Phase 2b trial of obicetrapib for preclinical Alzheimer's, shifting focus beyond cardiovascular indications.

Leadership TYFJ Sep 29 — 0.00

TOP Financial Appoints Anthony S. Chan

TOP Financial Group Ltd. amended the appointment letter of Independent Non-Executive Director Anthony S. Chan to update terms including compensation.

Leadership RNAC Sep 29 — 0.00

Cartesian reports durable responses in MG retreatment data

Cartesian Therapeutics announced deep and durable responses in a five-patient retreatment study of Descartes-08 for myasthenia gravis. The data supports the company's Phase 3 AUROR…

Leadership AQST Sep 29 — +0.10

Aquestive Therapeutics Appoints New Board Member

Aquestive Therapeutics named Richard Daly to its board of directors to help prepare for the potential commercial launch of its drug candidate, Anaphylm.

Leadership QS Sep 29 — 0.00

Quantum-Si Updates Prototypes at World HUPO 2026

Quantum-Si presented data and updates for the ProteusTM single-molecule protein sequencing platform at the World HUPO 2026 conference. The filing highlights an expected increase in…

Leadership ASTS Sep 28 — +0.10

AST SpaceMobile updates Change of Control severance policy

The company amended its Senior Management Change of Control Severance Policy to cover additional executive roles and standardize severance eligibility.

Leadership CRVO Sep 28 — 0.00

CervoMed Announces Neflamapimod Formulation Advancement

CervoMed has introduced a stable 50 mg tablet formulation to replace a previous capsule, paving the way for a higher, twice-daily dosing regimen. This regulatory and manufacturing …

Leadership SJT Sep 28 — 0.00

Press Release Issued in Response to Stakeholder Inquiries

The San Juan Basin Royalty Trust released an 8-K disclosing that it issued a press release on September 28, 2026, to provide additional information in response to inquiries from Un…